Literature DB >> 7123631

A possible null phenotype in the Cromer blood group complex.

G L Daniels, H Tohyama, M Uchikawa.   

Abstract

The red blood cells of a Japanese man failed to react with anti-Cra sera and with three Cromer-related sera, B.P., G.T., and K.T.O. His serum reacted with all red blood cells tested except his own. This phenotype, which may represent a null phenotype in the Cromer complex, supports the suggestion that the phenotypes of B.P., G.T., and K.T.O. are Cromer related.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7123631     DOI： 10.1046/j.1537-2995.1982.22583017458.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


  9 in total

1.  The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition.

Authors:  B Nowicki; A Labigne; S Moseley; R Hull; S Hull; J Moulds
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets.

Authors:  F A Spring; P A Judson; G L Daniels; S F Parsons; G Mallinson; D J Anstee
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen.

Authors:  B Nowicki; J Moulds; R Hull; S Hull
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

4.  Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype.

Authors:  C G Tate; M Uchikawa; M J Tanner; P A Judson; S F Parsons; G Mallinson; D J Anstee
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

5.  Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection.

Authors:  B Nowicki; L Truong; J Moulds; R Hull
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

Review 6.  Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.

Authors:  Tsutomu Shichishima; Hideyoshi Noji
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

Review 7.  Biological roles of blood group antigens.

Authors:  W L Marsh
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct

8.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.

Authors:  B Nowicki; A Hart; K E Coyne; D M Lublin; S Nowicki
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

9.  Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.

Authors:  M J Telen; S E Hall; A M Green; J J Moulds; W F Rosse
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.